替米沙坦及其类似物的合成和生物活性研究

设计合成了替米沙坦及其类似物, 改进了替米沙坦的合成工艺. 用邻苯二胺与相应的有机羧酸缩合, 所得产物苯并咪唑衍生物与4'-溴甲基联苯-2-甲酸甲酯通过N-烷基化得到相应的目标化合物, 合成了替米沙坦和9种未见文献报道的苯并咪唑联苯化合物, 其结构经¹H NMR, IR, MS和元素分析确证. 用体外动脉环的方法, 研究目标化合物的初步体外抗高血压活性, 试验结果表明其中部分化合物具有一定的抗高血压活性.     

新型吡唑n-硫代酰胺类衍生物的合成与杀菌活性

以水杨醛与丙酮缩合形成α,β不饱和酮,和硫代氨基脲关环形成吡唑硫代酰胺结构骨架,合成了7种未见文献报道的5-(2-羟基苯基)-3-甲基吡唑硫代酰胺类衍生物,并经过元素分析、红外光谱、核磁共振氢谱对其结构进行了表征。对新合成的化合物进行了初步生物活性测试。结果表明,化合物3c、3d和3g对大肠杆菌有一定的杀菌活性,最小全杀死质量浓度分别为250、250和500 mg/L;化合物3g对变形杆菌有一定的杀灭活性。     

6-氟-4-(N-芳基)胺基喹唑啉类化合物的微波合成及生物活性研究

经2-氨基-5-氟苯甲酸与甲酰胺闭环、氯化反应, 合成了6-氟-4-氯喹唑啉, 然后在微波辐射下与芳香胺反应, 合成了6个新的6-氟-4-(N-芳基)胺基喹唑啉类化合物. 新化合物经¹H NMR, IR及元素分析证明其结构. 体外抑瘤试验证明化合物对前列腺癌细胞(PC3)、人胃癌细胞(BGC823)、人乳腺癌细胞(BCap-37)均无抑制活性. 经ERK的抗磷酸化活性免疫印迹试验证明化合物对小鼠成纤维细胞(NIH3T3)无抑制活性.     

酰基吡唑啉酮缩氨基硫脲Ni(Ⅱ),Co(Ⅲ)和Cr(Ⅲ)配合物的合成、表征及生物活性

合成了含硫席夫碱1-苯基-3-甲基-4-(α-呋喃甲酰基)吡唑啉酮-5缩氨基硫脲(HL)及其Ni(Ⅱ),Co(Ⅲ)和Cr(Ⅲ)配合物.元素分析及摩尔电导率表明,新配合物的组成为[NiL2]·C2H5OH,[CoL2]Cl·H2O,[CrL2]Cl·1/2H2O.运用红外光谱、紫外光谱、核磁共振谱和磁矩对配合物进行了表征.抗菌实验表明,配合物具有较强的抗菌生物活性.     

钒（Ⅳ）与N，N，N＇，N″，N″─五苯并咪唑甲基二乙三胺多核配合物合成、ESR和生物活性

合成了两种新的Ｎ，Ｎ，Ｎ＇，Ｎ″，Ｎ″─五苯并咪唑甲基二乙三胺ＶＯ（Ⅱ）多核配合物并进行了元素分析、ＩＲ、ＵＶ─ｖｉｓ、ＥＳＲ等表征。求得了配合物的自旋Ｈａｍｉｌｔｏｎ参数，两配合物中Ｖ（Ⅳ）的电子环境差别较大。体外抗癌活性和农药活性测定结果表明配合物具有一定生物活性。     

呋喃甲酰基吡唑啉酮双席夫碱配合物的合成及其生物活性

呋喃甲酰基吡唑啉酮双席夫碱配合物的合成及其生物活性李锦州＊于文锦杜晓燕（哈尔滨师范大学化学系哈尔滨１５００８０）（哈尔滨医科大学公共卫生学院哈尔滨）关键词酰基吡唑啉酮，双席夫碱，配合物，合成，生物活性１９９７－０６－１６收稿，１９９７－０９－０９修回...     

N-茄呢基-N,N''''-二芳基乙二胺衍生物的合成与生理活性

以乙二胺，芳香醛和相应的卤代物为原料合成了N-茄呢基-N，N’-二（3，4-二甲氧基苄基）乙二胺（SBD-乙二胺）及三个新的衍生物．对L1210和CHO细胞初步的体外活性测试表明在SBD-乙二胺的仲氮上引入第四个取代基后，生成的衍生物对所测细胞的抑制活性提高，但对长春新碱的增效作用减弱．     

Printing biomacromolecules on a bovine serum albumin precursor layer

Various biomacromolecules including proteins and polysaccharides are printed on a substrate capped with a bovine serum albumin (BSA) precursor layer to create clear co-patterns of these molecules. Characterizations by confocal laser scanning microscopy (CLSM) and atomic force microscopy (AFM) demonstrate the successful production and clear boundaries of the co-patterns. Rinsing the BSA-adsorbed substrate and the biomacromolecules-inked stamp before microcontact printing (microCP) is crucial for the creation of clear and stable co-patterns. The patterns are mainly stabilized by electrostatic interactions and van der Waals forces. Characterizations by ellipsometry, UV-Vis and fluorescence spectroscopy reveal that printing by a flat PDMS stamp yields a denser layered structure of proteins with a higher amount than that of adsorbed proteins. By printing, however, a lower enzymatic catalytic activity for horseradish peroxidase (HRP) or binding capability for avidin (both normalized to amount) is determined. A conformational transition from alpha-helix to beta-sheet of HRP is observed by ATR-IR. By contrast, a BSA precursor layer can effectively improve the functionality of the printed HRP or avidin and preserve the original conformation of the proteins, although the absolute transferred amount of these proteins is decreased.     

Bioactive Ca10(PO4)6(OH)2−TiO2 composite coating prepared by sol-gel process

The sol-gel prepared titania (TiO₂) has recently been demonstrated with a promising bioactivity [1]. It forms a chemical bond with the living bone in the body, although the bonding is not very strong. The present study is intended to improve the bone-bonding ability of the titania gel. The goal is achieved by impregnating the titania with hydroxyapatite (Ca₁₀(PO₄)₆(OH)₂). The processing route includes the following steps: (1) the titania sol solution was prepared; (2) the solution was mixed with fine hydroxyapatite (HA) powders; (3) the mixture was used to produce a coating on a commercial pure titanium (c.p. Ti) or Ti6A14V plate by a dip coating technique; (4) the coating was fired at 400–600°C. The resulting coating is a composite consisting of hydroxyapatite embedded in the matrix of the titania gel. Such HA-TiO₂ composite coating is capable of inducing the hydroxyapatite precipitation from a simulated body fluid. When implanted in femurs of goat, the composite coating shows a bonding with bone. Its bone-bonding strength is twice as high as that of the pure titania gel coating. The results indicate that impregnating with hydroxyapatite is a promising way to increase the bioactivity of the titania gel.     

双核Cu(II)-牛磺酸缩水杨醛席夫碱配合物的合成、晶体结构及生物活性

合成了双核铜配合物 [Cu(TSSB) (H2 O) ] 2 ·2H2 O (TSSB =牛磺酸缩水杨醛席夫碱 ) ,通过元素分析、红外光谱对配合物进行了表征 ,并利用X射线法测定其结构 .晶体属三斜晶系 ,空间群P1- ,其晶胞参数为 :a =0 .69613 ( 19)nm ,b =0 .93 0 7( 3 )nm ,c=1.0 43 9( 3 )nm ;α =10 8.796( 5 )° ,β =10 1.2 71( 5 )° ,γ =10 5 .617( 5 )° ,V =0 .5 869( 3 )nm3 ,Z =1,Dcald=1.849g/cm3 ,μ =2 .0 5 8mm-1,F( 0 0 0 ) =3 3 4,Gof =1.0 79,Δρ =3 79～ -4 0 6e·nm-3 .两个铜原子配位数各为五 ,处于变形四方锥的配位环境中 .并对配合物进行了的生物活性试验 ,结果表明 ,配合物抗菌活性与青霉素接近 ,肿瘤抑制率达 63 .5 % .半数致死量为 10 0 0mg/kg .有可能成为一种新的抗菌、抗肿瘤药物